Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jun 14;21(1):148.
doi: 10.1186/s13075-019-1932-9.

Testing the effects of gentle vibrotactile stimulation on symptom relief in fibromyalgia

Affiliations
Randomized Controlled Trial

Testing the effects of gentle vibrotactile stimulation on symptom relief in fibromyalgia

Jesus Pujol et al. Arthritis Res Ther. .

Abstract

Background: Sensory disturbances in fibromyalgia extend beyond nociception. It has been proposed that imbalance in the mutual competition between painful input and non-painful sensory activity may, to a significant extent, account for the augmented subjective perception of pain. In this context, non-nociceptive somatosensory stimulation could arguably attenuate fibromyalgia symptoms by restoring the sensory balance. We specifically tested the effect of vibrotactile stimulation on symptom relief in fibromyalgia patients with a randomized, double-blind, sham-controlled, crossover clinical trial.

Methods: Seventy-seven female patients were randomized and data from 63 valid cases were analyzed. Active intervention involved extensive body stimulation with gentle mechanical vibrations administered during 3 h at night for 3 weeks, and the placebo effect was controlled using identical instruments to simulate an alternative treatment option. The primary outcome measure combined pain, fatigue, and complaints of poor cognition.

Results: Vibrotactile stimulation was significantly superior to sham in alleviating fibromyalgia symptoms globally. However, univariate analyses showed that the effect was not universal. Benefits were perceived on unpleasant somatic sensations such as generalized pain and fatigue, but not on poor cognition, anxiety, and depression. Vibrotactile stimulation was notably well tolerated and sleep quality significantly improved despite the fact that vibrations were administered at night.

Conclusions: Results thus provide new evidence that non-nociceptive somatosensory stimulation may favorably act upon altered somatosensory balance in fibromyalgia. From a clinical perspective, both the degree of improvement and the easy application of our proposal would seem to support a potential role for vibrotactile stimulation in the symptomatic treatment of fibromyalgia.

Trial registration: ClinicalTrials.gov registration number NCT03227952 . Registered 24 July, 2017.

Keywords: Fibromyalgia; Pain; Sensory balance; Somatosensory system; Vibrotactile stimulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Instruments used to administer vibrotactile stimulation (above) and sham (bottom). An electronic engine controlled stimuli delivery. Mechanical vibrotactile stimuli were generated using 6 vibration motors fitted into a standard mattress. Sham treatment was applied using identical instruments, with an electrical signal turning on a pilot light to indicate that the (simulated) treatment was operative
Fig. 2
Fig. 2
CONSORT flow diagram
Fig. 3
Fig. 3
Bar graphs showing NRS score reduction for the three fibromyalgia key symptoms
Fig. 4
Fig. 4
Bar graphs showing NRS score reduction for fatigue separately for each allocation group to illustrate the intervention order effect

Similar articles

Cited by

References

    1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600–610. doi: 10.1002/acr.20140. - DOI - PubMed
    1. Gracely RH, Ambrose KR. Neuroimaging of fibromyalgia. Best Pract Res Clin Rheumatol. 2011;25:271–284. doi: 10.1016/j.berh.2011.02.003. - DOI - PubMed
    1. López-Solà M, Woo CW, Pujol J, Deus J, Harrison BJ, Monfort J, Wager TD. Towards a neurophysiological signature for fibromyalgia. Pain. 2017;158:34–47. doi: 10.1097/j.pain.0000000000000707. - DOI - PMC - PubMed
    1. Napadow V, Harris RE. What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of ‘centralized’ pain? Arthritis Res Ther. 2014;16:425. doi: 10.1186/s13075-014-0425-0. - DOI - PMC - PubMed
    1. López-Solà M, Pujol J, Wager TD, Garcia-Fontanals A, Blanco-Hinojo L, Garcia-Blanco S, Poca-Dias V, Harrison BJ, Contreras-Rodríguez O, Monfort J, Garcia-Fructuoso F, Deus J. Altered functional magnetic resonance imaging responses to nonpainful sensory stimulation in fibromyalgia patients. Arthritis Rheumatol. 2014;66:3200–3209. doi: 10.1002/art.38781. - DOI - PMC - PubMed

Publication types

Associated data